Trexquant Investment’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Trexquant Investment’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-6,922	Closed	-$230K	–	1664
2020 Q2	$230K	Sell	6,922 -14,070	-67%	-$448K	0.02%	996
2020 Q1	$571K	Buy	+20,992	New	+$584K	0.04%	614
2019 Q4	–	Sell	-12,983	Closed	-$168K	–	1356
2019 Q3	$168K	Sell	12,983 -2,934	-18%	-$35.4K	0.01%	773
2019 Q2	$198K	Buy	+15,917	New	+$211K	0.02%	693
2018 Q4	–	Sell	-18,348	Closed	-$483K	–	1423
2018 Q3	$483K	Buy	+18,348	New	+$496K	0.04%	549
2016 Q2	–	Sell	-25,693	Closed	-$237K	–	1210
2016 Q1	$237K	Sell	25,693 -40,617	-61%	-$437K	0.03%	806
2015 Q4	$984K	Buy	+66,310	New	+$1.11M	0.09%	400
2015 Q3	–	Sell	-88,900	Closed	-$2.03M	–	1356
2015 Q2	$2.03M	Buy	+88,900	New	+$1.77M	0.23%	88
2015 Q1	–	Sell	-34,900	Closed	-$420K	–	1272
2014 Q4	$420K	Buy	+34,900	New	+$399K	0.07%	536

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Trexquant Investment's MNTA Position: Q3 2020 in Review

Trexquant Investment sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 6,922 shares — an estimated $230K sold.

Trexquant Investment first reported a position in MNTA in Q4 2014 and held it in 9 quarters. The position peaked at $2.03M in Q2 2015. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

Trexquant Investment reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Trexquant Investment sold 6,922 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $230K.
Trexquant Investment first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2014 and held it in 9 quarters.
Trexquant Investment's Momenta Pharmaceuticals, Inc. position peaked at $2.03M in Q2 2015.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Trexquant Investment's 13F filing for Q3 2020, filed 6 Nov 2020.